Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of the word XIPERE beginning with a capital "X" followed by the capital letter "I" with an arc-like line beginning at the bottom
of the letter I and continuing through the center of the letters P, E, and ending at the bottom of the letter R followed by a capital "E".
PIXEL COUNT ACCEPTABLE
YES
PIXEL COUNT
944 x 250
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Clearside Biomedical, Inc.
*STREET
900 North Point Parkway, Suite 200
*CITY
Alpharetta
*STATE
(Required for U.S. applicants)
Georgia
*COUNTRY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
30005
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY OF INCORPORATION
Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
Ocular pharmaceuticals; Ophthalmic preparations
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
010
*IDENTIFICATION
Medical devices, namely, a needle-based injection system for delivery of pharmaceuticals and injection needles; Ophthalmic medical devices,
namely, a needle-based injection system for delivery of pharmaceuticals to eye tissue and injection needles; drug delivery systems
FILING BASIS
SECTION 1(b)
ATTORNEY INFORMATION
NAME
Bassam N. Ibrahim
ATTORNEY DOCKET NUMBER
0080003-115
FIRM NAME
Buchanan Ingersoll & Rooney, PC
STREET
1737 King Street, Suite 500
CITY
Alexandria
STATE
Virginia
COUNTRY
United States
ZIP/POSTAL CODE
22314
PHONE
703-836-6620
FAX
703-836-2021
EMAIL ADDRESS
bassam.ibrahim@bipc.com
AUTHORIZED TO COMMUNICATE VIA EMAIL
Yes
OTHER APPOINTED ATTORNEY
Bryce J. Maynard, Laura K. Pitts, and all other attorneys of the firm
CORRESPONDENCE INFORMATION
NAME
Bassam N. Ibrahim
FIRM NAME
Buchanan Ingersoll & Rooney, PC
STREET
1737 King Street, Suite 500
CITY
Alexandria
STATE
Virginia
COUNTRY
United States
ZIP/POSTAL CODE
22314
PHONE
703-836-6620
FAX
703-836-2021
*EMAIL ADDRESS
bassam.ibrahim@bipc.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL
Yes
FEE INFORMATION
APPLICATION FILING OPTION
TEAS RF
NUMBER OF CLASSES
2
APPLICATION FOR REGISTRATION PER CLASS
275
*TOTAL FEE DUE
550
*TOTAL FEE PAID
550
SIGNATURE INFORMATION
SIGNATURE
NOT PROVIDED
SIGNATORY'S NAME
NOT PROVIDED
SIGNATORY'S POSITION
NOT PROVIDED
DATE SIGNED
NOT PROVIDED
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
Serial Number:88221046
Filing Date:12/07/2018
To the Commissioner for Trademarks:
MARK: XIPERE (stylized and/or with design, see mark)
The literal element of the mark consists of XIPERE.
The applicant is not claiming color as a feature of the mark. The mark consists of the word XIPERE beginning with a capital "X" followed by the capital letter "I" with an arc-like line beginning at
the bottom of the letter I and continuing through the center of the letters P, E, and ending at the bottom of the letter R followed by a capital "E".
The applicant, Clearside Biomedical, Inc., a corporation of Delaware, having an address of
900 North Point Parkway, Suite 200
Alpharetta, Georgia 30005
United States
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: Ocular pharmaceuticals; Ophthalmic preparations
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 010: Medical devices, namely, a needle-based injection system for delivery of pharmaceuticals and injection needles; Ophthalmic medical
devices, namely, a needle-based injection system for delivery of pharmaceuticals to eye tissue and injection needles; drug delivery systems
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The applicant's current Attorney Information:
Bassam N. Ibrahim and Bryce J. Maynard, Laura K. Pitts, and all other attorneys of the firm of Buchanan Ingersoll & Rooney,
PC 1737 King Street, Suite 500
Alexandria, Virginia 22314
United States
703-836-6620(phone)
703-836-2021(fax)
bassam.ibrahim@bipc.com (authorized)
The attorney docket/reference number is 0080003-115.
The applicant's current Correspondence Information:
Bassam N. Ibrahim
Buchanan Ingersoll & Rooney, PC
1737 King Street, Suite 500
Alexandria, Virginia 22314
703-836-6620(phone)
703-836-2021(fax)
bassam.ibrahim@bipc.com (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at
the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent
application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional
processing fee of $125 per international class of goods/services.
A fee payment in the amount of $550 has been submitted with the application, representing payment for 2 class(es).
Declaration
Declaration Signature
Signature: Not Provided Date: Not Provided
Signatory's Name: Not Provided
Signatory's Position: Not Provided
Payment Sale Number: 88221046
Payment Accounting Date: 12/07/2018
Serial Number: 88221046
Internet Transmission Date: Fri Dec 07 13:05:11 EST 2018
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.XX-201812071305111
10116-88221046-610cfefecf0f3936d64a61c48
ba39e4fbae74f8d748f126d99786725077198135
77-CC-13558-20181207125605057813